• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Restenosis (4576)
Date of Event 09/19/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history records will be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.D4 (expiry date: 09/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event or Problem Description
It was reported through the results of a clinical trial that five months and twenty-two days post index procedure using a drug-coated balloon catheter in the cephalic vein, the subject developed an adverse event of restenosis of the target lesion which required an arteriovenous access circuit reintervention.It was further reported that the target lesion in the left forearm had fifty-seven percent initial stenosis and nine percent final residual stenosis.Furthermore, standard percutaneous transluminal angioplasty procedure was performed for the treatment.Reportedly, the treatment re-intervention was successful, a new access was not created, and the outcome of adverse event was resolved.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: (expiration date: 09/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text: device not returned.
 
Event or Problem Description
It was reported through the results of a clinical trial that five months and twenty-two days post index procedure using a drug-coated balloon catheter in the cephalic vein, the subject developed a serious adverse event of restenosis of the cephalic vein in the target lesion which required an arteriovenous access circuit re-intervention.It was further reported that the target lesion in the left forearm had fifty-seven percent initial stenosis and nine percent final residual stenosis.Furthermore, standard percutaneous transluminal angioplasty procedure was performed for the treatment.Reportedly, the treatment re-intervention was successful, a new access was not created, and the outcome of serious adverse event was resolved.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED BALLOON PTA CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key17981778
Report Number3006513822-2023-00041
Device Sequence Number14332237
Product Code PRC
UDI-Device Identifier00801741135460
UDI-Public(01)00801741135460
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/26/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number9010
Device Catalogue NumberLX3575860V
Device Lot NumberGFGT1979
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 10/02/2023
Supplement Date Received by Manufacturer12/26/2023
Initial Report FDA Received Date10/21/2023
Supplement Report FDA Received Date12/29/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/13/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age59 YR
Patient SexMale
Patient Weight96 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-